csl689
Recombinant proteinexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02470871)
Timeline
Indications
Mechanism of action
- Coagulation factor VIISupplementation
F7 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- csl689
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02470871 | Phase 1 | Jul 1, 2015 | CSL Behring |
| NCT02484638 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2015 | CSL Behring |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CSL Behring | For profit | 2 | 2 | 2 | 2015 |
1 organizations
Page 1 / 1